Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 4, 2013, Pages 283-288

  Alkharfy, Khalid M ^a,b   Al Daghri, Nasser M ^b,c   Yakout, Sobhy M ^b   Hussain, Tajamul ^b   Mohammed, Abdul Khader ^b   Krishnaswamy, Soundararajan ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CALCITRIOL; DIET, HIGH-FAT; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MUSCLES; OBESITY; RECEPTOR, INSULIN; RECEPTORS, CALCITRIOL; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

EID: 84880445006     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0068     Document Type: Article

References (47)

1. Emanuela F, Grazia M, Marco de R, et al. Inflammation as a link between obesity and metabolic syndrome. J Nutr Metab 2012:476380.
2. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
3. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005;5: 70-75.
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919; quiz 920.
5. Bilan PJ, Samokhvalov V, Koshkina A, et al. Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Arch Physiol Biochem 2009;115:176- 190.
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.
7. Xu H, Barnes GT, Yang Q, et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
8. Arkan MC, Hevener AL, Greten FR, et al., IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198.
9. Kim JK, Kim YJ, Fillmore JJ, et al., Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001;108:437-446.
10. Yuan M, Konstantopoulos N, Lee J, et al., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001;293:1673-1677.
11. Colston K, Hirt M, Feldman D. Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology 1980;107:1916-1922.
12. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl): 1689S-1696S.
13. Riachy R, Vandewalle B, Kerr Conte J, et al. 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: Implication of the antiapoptotic protein A20. Endocrinology 2002;143:4809-4819.
14. Maggini S,Wintergerst ES, Beveridge S, et al. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 2007;98(Suppl 1):S29-S35.
15. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101.
16. Scragg R, Holdaway I, Singh V, et al. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance VITAMIN D REGULATION OF INSULIN-SENSITIVE GENES 287 and diabetes mellitus. Diabetes Res Clin Pract 1995;27:181- 188.
17. Knekt P, Laaksonen M, Mattila C, et al., Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666-671.
18. Forouhi NG, Luan J, Cooper A, et al. Baseline serum 25- hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-2625.
19. Olson ML, Maalouf NM, Oden JD, et al. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012;97:279-285.
20. Roth CL, Elfers C, Kratz M, et al. Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes 2011:495101.
21. Baynes KC, Boucher BJ, Feskens EJ, et al. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997;40:344-347.
22. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825.
23. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010;103:549-555.
24. de Souza Santos R, Vianna LM. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta 2005;358:146-150.
25. Stentz FB, Kitabchi AE. Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 2007;5:216-235.
26. Calle C, Maestro B, Garcia-Arencibia M. Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol 2008;9:65.
27. Alkharfy KM, Al-Daghri NM, Yakout SM, et al. Calcitriol attenuates weight-related systemic inflammation and ultrastructural changes of the liver in a rodent model. Basic Clin Pharmacol Toxicol 2012;112:42-49.
28. Healy KD, Frahm MA, DeLuca HF. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization. Arch Biochem Biophys 2005;433:466-473.
29. Quesada JM, Martin-Malo A, Santiago J, et al., Effect of calcitriol on insulin secretion in uraemia. Nephrol Dial Transplant 1990;5:1013-1017.
30. Ishida H, Seino Y, Seino S, et al., Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function. Life Sci 1983;33:1779-1786.
31. Cade C, Norman AW. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 1987;120:1490-1497.
32. Mathieu C, Van Etten E, Gysemans C, et al., In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 2001;16:2057-2065.
33. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr 1998; 79:315-327.
34. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230.
35. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-2818.
36. Huang Y, Ishizuka T, Miura A, et al., Effect of 1 alpha,25- dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes. Diabetes Res Clin Pract 2002;55:175-183.
37. Tai K, Need AG, Horowitz M, et al. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008;24:950-956.
38. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010:351385.
39. Pereira F, Barbachano A, Singh PK, et al. Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 15;11:1081-1089.
40. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;15:5789-5799.
41. O'Connell TD, Simpson RU. 1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart. Biochem Biophys Res Commun 1995;213:59-65.
42. Dickie LJ, Church LD, Coulthard LR, et al. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford). 2010;49:1466-1471.
43. Dearth RK, Cui X, Kim HJ, et al., Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 2006;26:9302-9314.
44. Siddiqui SM, Chang E, Li J, et al., Dietary intervention with vitamin D, calcium, and whey protein reduced fat mass and increased lean mass in rats. Nutr Res 2008;28:783-790.
45. Zineb R, Zhor B, Odile W, et al. Distinct, tissue-specific regulation of vitamin D receptor in the intestine, kidney, and skin by dietary calcium and vitamin D. Endocrinology 1998; 139:1844-1852.
46. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitamins Hormones 2006;74:443-477.
47. Cohen-Lahav M, Shany S, Tobvin D, et al. Vitamin D decreases NFkB activity by increasing IkBa levels. Nephrology Dialysis Transplant 2006;21:889-897.